PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study



Status:Active, not recruiting
Conditions:Colorectal Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/14/2018
Start Date:October 2012
End Date:October 2019

Use our guide to learn which trials are right for you!

PET/MRI as a Predictor for Response to Preoperative Radiation Therapy and Chemotherapy in Resectable Rectal Cancer: a Pilot Study.

This is a single arm, single center pilot study of 40 patients with uT3N0 or uT1-3N+ rectal
cancer receiving pre-operative chemoradiation. Subjects will undergo PET/MRI scans before and
after surgery.

The primary purpose of this study is to determine the negative predictive value of PET/MRI
for determining pathological complete response from neoadjuvant chemoradiation.

Inclusion Criteria:

- Low-lying, low- to moderate-risk pathologically-confirmed rectal cancer (stage uT3n)
or uT1-3N+

- Negative workup for distant disease

- > 18 years of age

- Pre-treatment workup completed including:

- history and physical

- CT or MRI of the abdomen and pelvis

- endoscopic tumor evaluation (biopsy, blood work to assess CEA and hematopoietic, renal
and liver function)

- if female of child-bearing age, negative pregnancy test

- Recommendation to undergo preoperative concurrent chemoradiation, as determined by the
treating physician

- Informed consent reviewed and signed

Exclusion Criteria:

- Not deemed a candidate for preoperative chemoradiation for medical reasons, such as
uncontrolled infection (including HIV), uncontrolled diabetes mellitus or cardiac
disease

- Hemoglobin ≤ 10.0 g/dL (transfusion allowed to achieve or maintain levels)

- ANC ≤ 1,500/cubic mm³

- Platelet count ≤ 100,000/mm³

- ALT and AST ≥ 2.5 times upper level of normal (ULN)

- Alkaline phosphatase ≥ 2.5 times ULN

- Total bilirubin ≥ 1.5 times ULN

- Creatinine clearance < 50 mL/min

- Creatinine ≥ 1.5 times ULN

- Not deemed a candidate for concurrent preoperative chemoradiation for social reasons,
such as psychiatric illness

- Not deemed a surgical candidate

- Currently active second malignancy, except non-melanoma skin cancer, non-invasive
bladder cancer, low risk adenocarcinoma of the prostate and carcinoma in situ of the
cervix

- Previous pelvic radiation therapy

- History of severe reaction to gadolinium

- Inability to tolerate MRI (e.g., inability to lie flat for > 1 hour)

- Presence of a pacemaker, intracranial aneurysm clip, bladder stimulator, cochlear
implant or metal near eyes

- Body Mass Index (BMI) > 35

- Pregnant or lactating female
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials